A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting

Journal of Nuclear Medicine

Volumn 55, Issue 10, 2014, Pages 1706-1711

  Pérez Medina, Carlos ^a,b,c   Abdel Atti, Dalya ^d   Zhang, Yachao ^d   Longo, Valerie A ^d   Irwin, Chrisopher P ^d   Binderup, Tina ^c,e   Ruiz Cabello, Jesús ^a,b   Fayad, Zahi A ^c   Lewis, Jason S ^d   Mulder, Willem J M ^c   Reiner, Thomas ^d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

89Zr; Breast cancer; Liposomes; Near infrared imaging; PET

Indexed keywords

CLICK LABELED LIPOSOME ZR 89; RADIOPHARMACEUTICAL AGENT; SURFACE CHELATION LIPOSOME ZR 89; UNCLASSIFIED DRUG; CHELATING AGENT; FLUORESCENT DYE; LIPID BILAYER; LIPOSOME; NANOPARTICLE; ZIRCONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CHEMICAL PROCEDURES; CLICK LABELING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TUMOR LEVEL; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; IMAGING AND DISPLAY; IN VIVO STUDY; INTRAOPERATIVE PERIOD; MOLECULAR PROBE; MOLECULAR STABILITY; MOUSE; MOUSE MODEL; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; SURFACE CHELATION; ANIMAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; LIPID BILAYER; NANOTECHNOLOGY; NEOPLASM; PROCEDURES; SCINTISCANNING;

ANIMALS; CHELATING AGENTS; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; LIPID BILAYERS; LIPOSOMES; MICE; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; ZIRCONIUM;

EID: 84907558689     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.141861     Document Type: Article

References (39)

1. Cheng MM, Cuda G, Bunimovich YL, et al. Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol. 2006;10:11-19.
2. Schroeder A, Heller DA, Winslow MM, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2012;12:39-50.
3. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36-48.
4. Jin H, Heller DA, Kalbacova M, et al. Detection of single-molecule H2O2 signalling from epidermal growth factor receptor using fluorescent single-walled carbon nanotubes. Nat Nanotechnol. 2010;5:302-309.
5. Tassa C, Duffner JL, Lewis TA, et al. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug Chem. 2010;21:14-19.
6. Fan R, Vermesh O, Srivastava A, et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol. 2008;26:1373-1378.
7. Haun JB, Devaraj NK, Hilderbrand SA, Lee H, Weissleder R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol. 2010;5:660-665.
8. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA. 2008;105:7387-7392.
9. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small. 2007;3:1840-1854.
10. Maeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65: 71-79.
11. Smith BR, Ghosn EE, Rallapalli H, et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol. 2014;9:481-487.
12. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387-6392.
13. Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids. 2009;162:1-16.
14. Chauhan VP, Stylianopoulos T, Martin JD, et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol. 2012;7:383-388.
15. Luk BT, Fang RH, Zhang L. Lipid-and polymer-based nanostructures for cancer theranostics. Theranostics. 2012;2:1117-1126.
16. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145-160.
17. Mullard A. Molecular imaging as a de-risking tool: coming into focus? Nat Rev Drug Discov. 2013;12:251-252.
18. Hargreaves RJ. The role of molecular imaging in drug discovery and development. Clin Pharmacol Ther. 2008;83:349-353.
19. Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73:2412-2417.
20. Sanhai WR, Sakamoto JH, Canady R, Ferrari M. Seven challenges for nanomedicine. Nat Nanotechnol. 2008;3:242-244.
21. Petersen AL, Binderup T, Rasmussen P, et al. 64Cu loaded liposomes as positron emission tomography imaging agents. Biomaterials. 2011;32:2334-2341.
22. Gaykema SB, Brouwers AH, Lub-de Hooge MN, et al. 89Zr-bevacizumab PET imaging in primary breast cancer. J Nucl Med. 2013;54:1014-1018.
23. Nahrendorf M, Keliher E, Marinelli B, et al. Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci USA. 2010;107:7910-7915.
24. Cohen R, Vugts DJ, Stigter-van Walsum M, Visser GW, van Dongen GA. Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single-or dual-mode fluorescence and PET imaging. Nat Protoc. 2013;8: 1010-1018.
25. Algar WR, Prasuhn DE, Stewart MH, et al. The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry. Bioconjug Chem. 2011;22:825-858.
26. Reiner T, Zeglis BM. The inverse electron demand Diels-Alder click reaction in radiochemistry. J Labelled Comp Radiopharm. 2014;57:285-290.
27. Zeng D, Zeglis BM, Lewis JS, Anderson CJ. The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. J Nucl Med. 2013;54:829-832.
28. Wong CH, Zimmerman SC. Orthogonality in organic, polymer, and supramolecular chemistry: from Merrifield to click chemistry. Chem Commun (Camb). 2013;49:1679-1695.
29. Liang Y, Mackey JL, Lopez SA, Liu F, Houk KN. Control and design of mutual orthogonality in bioorthogonal cycloadditions. J Am Chem Soc. 2012;134: 17904-17907.
30. Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25:1165-1170.
31. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6:715-728.
32. Riviere JE. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:26-34.
33. Almeida JP, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011;6:815-835.
34. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond). 2008;3:703-717.
35. Abou DS, Thorek DL, Ramos NN, et al. 89Zr-Labeled paramagnetic octreotideliposomes for PET-MR imaging of cancer. Pharm Res. 2013;30:878-888.
36. Zeglis BM, Mohindra P, Weissmann GI, et al. Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry. Bioconjug Chem. 2011;22:2048-2059.
37. Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S. 89Zr-radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors. Pharmaceuticals (Basel). 2012;5:79-93.
38. Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13:125-138.
39. Pittet MJ, Weissleder R. Intravital imaging. Cell. 2011;147:983-991.